Traduction de «Assurance mortalité pour animaux de grande valeur » (Français → Anglais) :

(ii) the mortality rates for current and former contributors, including mortality projection factors, used in the preparation of the report referred to in subparagraph (i), or the mortality rates, including mortality projection factors, referred to in the section entitled “Pension Commuted Values” of the Standards of Practice – Practice-Specific Standards for Pension Plans (the “Standards”), published by the Canadian Institute of Actuaries, as amended from time to time, whichever will produce the greater actuarial present value of a member’s accrued pensi ...[+++]on benefits;

Thirdly, for the higher-value animals, a system should be in place to compensate producers for high-value animals identified beforehand that have to be eliminated.

In some cases, for high-value animals, or in particular cases, as one of the panel mentioned earlier, some of those additional costs were funded through other sources, either industry funds.that we currently can't pay unless there's a change to the Health of Animals Act.

It is recommended that the minimum size for an indoor enclosure should meet the minimum values specified to ensure that the animals are not overcrowded in inclement weather.

(5) On 15 May 2001 the European Parliament adopted a Resolution(6) on both Commission Communications on the subject recognising that the eLearning initiative is helping to strengthen the idea of a "single European educational area", which complements the European research area and the European single market, and calling for it to be developed independently under a new specific programme, with a clear legal basis, avoiding duplication with existing programmes and providing more visibility and added value to Community action.

COUNCIL RESOLUTION DESIGNED TO IMPLEMENT THE OUTLINES OF AN INDUSTRIAL POLICY IN THE PHARMACEUTICAL SECTOR IN THE EUROPEAN UNION THE COUNCIL Having regard to the Commission communication of 14 September 1994 entitled "An industrial competitiveness policy for the European Union"; Recalling its Resolution of 21 November 1994 on strengthening the competitiveness of Community industry [10] , and its conclusions of 7 April 1995 on an industrial competitiveness policy; Having regard to the communication of 2 March 1994 from the Commission to the Council and the European Parliament on the outlines of an industrial policy for the pharmaceutical sector in the European Union; Whereas the European Union has an important role to play in c ...[+++]reating a favourable environment for the expansion of activities relating to research, development, production and distribution of medicinal products and in encouraging the development of an innovative and effective European pharmaceutical industry in terms of competitiveness on the world market; Whereas European industrial policy must necessarily take account of the special nature of this sector, which relates both to public health and to social policy; whereas social security systems bear a considerable proportion of pharmaceutical expenditure; whereas this is a matter which falls within the competence of the Member States; Whereas the European Union has the responsibility of sketching out guidelines for the promotion of Community activities in this sector, HAS ADOPTED THIS RESOLUTION: I. WITH RESPECT TO THE SITUATION IN THE PHARMACEUTICAL INDUSTRY 1. recalls that the European pharmaceutical industry plays an essential role in public health, remains a high-technology industry with considerable added value, which is particularly successful, generates highly skilled jobs and makes a significant contribution to the Union's balance of trade; 2. considers that, now that it is facing increasingly intense international competition, the Euro ...